SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Tehran synagogue damaged by missile strike according to Iranian media - 2Analysis-From 'Icarus bug' to flawed panels: Airbus counts cost of relying on single model
- 3Blue Origin’s New Glenn rocket landed its booster on a barge at sea – an achievement that will broaden the commercial spaceflight market
- 4Home Remodel Administrations: Change Your Residing Space
- 5Noctourism: the new safari travel trend that's changing the wildlife we can photograph in Africa
- The Best Cell phone Brands for Tech Lovers
- How to watch 'A Charlie Brown Christmas' for free this weekend
- IDF begins destroying homes used by Hezbollah as forces move deeper into southern Lebanon
- People with depression can treat themselves at home with new device
- The Tradition of Stone: A Gander at Notable Structures Through the Ages
- China and Pakistan issue five-point peace plan for Middle East
- The next frontier in space is closer than you think – welcome to the world of very low Earth orbit satellites
- Manual for Savvy Home Lighting Framework: Lights up Your Space
- Chinese construction workers in Israel: 'I’d rather be bombed than live in poverty'
